Skeletal Health Outcomes among US Asian Women
Skeletal Health Outcomes among US Asian Women
批准号:
10665062
负责人:
Joan C Lo
金额:
$55.53万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-15 至 2026-06-30
关键词:
AddressAgeAgingAreaAsianAsian AmericansAsian populationBlack PopulationsBone DensityCalibrationCaliforniaCaringCaucasiansChinaChineseClinicalClinical ManagementCounselingCountryDataDatabasesDiagnosisEast AsianElectronic Health RecordEpidemiologyEthnic OriginEthnic PopulationEventFemoral FracturesFemurFilipinoFractureFutureGenderHealthHealthcareHip FracturesHip region structureHispanicHispanic PopulationsHomeHong KongIncidenceIntegrated Delivery of Health CareIntegrated Health Care SystemsJapaneseKnowledgeKoreansNeckOnline SystemsOsteoporosisOutcomePharmaceutical PreparationsPhilippinesPopulationPopulation HeterogeneityPreventionProbabilityRaceRecommendationReportingRiskRisk AssessmentRisk EstimateSan FranciscoSouth AsianSoutheastern AsiaSubgroupSystemTaiwanTest ResultTestingUnited States Preventative Services Task ForceUpdateVariantVietnameseWomanWristbisphosphonatediagnostic toolepidemiology studyethnic diversityethnic minorityfracture riskhazardhealth planhuman old age (65+)humerusmembermenolder patientosteoporosis with pathological fractureovertreatmentpopulation basedpredictive toolsrisk predictionscreeningskeletalsoutheast Asianspine bone structurestemtooltreatment optimization
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Both ethnic diversity and the burden of osteoporosis have increased with the aging US population. Asians now
comprise 7% of the US and 17% of California’s population, the state in which nearly one third of all US Asians
reside. In 2002, the US Preventive Services Task Force updated recommendations for osteoporosis screening
to all women age 65 years and older. Because Asians have lower bone density than whites, they have a
greater likelihood of being diagnosed with osteoporosis on the basis of their bone density screening test
results, yet they have a lower risk of hip fracture. Existing fracture risk calculators consider race/ethnicity in
estimating fracture risk, but the inherent assumptions remain largely untested. The most widely used calculator
is FRAX, which provides 10-year risk estimates of hip and any one of four major osteoporotic fractures for
white, black, Hispanic, and Asian race. For US Asians, an adjustment factor (0.5 for women) is applied during
fracture risk calculation, based on epidemiologic studies indicating that US Asian women have a 40-50% lower
incidence of hip fracture than white women. However, data for fractures other than hip are limited for Asians,
and population fracture data by Asian ethnic subgroups are largely lacking. US Asians comprise a
heterogeneous population whose ancestry originates primarily from East, South, and Southeast Asia; in
California, the two largest subgroups are Filipino and Chinese. It is notable that using the same age, gender,
bone density, and clinical profile, FRAX calculators produce different results for US Asian versus Asians in
Hong Kong and Taiwan (both higher), China (similar), and the Philippines (lower). These differences could
stem from differences in fracture epidemiology in these countries. A more precise understanding of fracture
risk in US Asians is paramount for tailoring their fracture prevention counseling and care.
Using data from Kaiser Permanente Northern California, a large integrated healthcare delivery system with
membership across Northern California and especially in the San Francisco Bay Area and Sacramento regions
(where large numbers of Asians reside), this proposed study will conduct the first large-scale assessment of
bone density and fracture outcomes among US Asians and Asian ethnic minorities. Our three primary aims
are: (1) to compare the incidence of hip and major osteoporotic fractures for white and Asian men and women
and by Asian ethnic minorities; (2) to characterize the association between bone density and fracture risk for
Asian women in relation to findings observed for white women; and (3) to examine the predictive accuracy of
fracture risk tools for Asian women and to determine whether replacement of existing base population fracture
data with Asian-specific fracture data yields more accurate fracture risk prediction for Asians. Findings from
this study will provide a more accurate way to calculate fracture risk in US Asians and, in the future, could
enable millions of Asian Americans to obtain fracture risk data tailored to their ethnic profile.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Differences in proximal humerus and wrist fracture incidence among US Asian subgroups.
美国亚裔亚群之间肱骨近端和腕部骨折发生率的差异。
DOI:
10.1111/jgs.18408
发表时间:
2023
期刊:
Journal of the American Geriatrics Society
影响因子:
6.3
作者:
[Lo,JoanC, Lee,DavidR, Chandra,Malini, Zeltser,DavidW, Chu,ClarenceE, Gordon,NancyP, Darbinian,JeanneA, Lee,Catherine]
通讯作者:
Lee,Catherine
Racial and Ethnic Variation in Dementia Prevalence in a Diverse Cohort of Adults with Hip Fracture.
不同髋部骨折成年人群体中痴呆症患病率的种族和民族差异。
DOI:
10.1007/s11606-023-08578-6
发表时间:
2024
期刊:
Journal of general internal medicine
影响因子:
5.7
作者:
[Lee,DavidR, Lo,JoanC, Chandra,Malini, Lee,Catherine, Gilsanz,Paola]
通讯作者:
Gilsanz,Paola
Skeletal Health Outcomes among US Asian Women
-
批准号:10096288
-
项目类别:
-
资助金额:$55.53万
-
财政年份:2021
-
负责人:Joan C Lo
-
依托单位:
Femur Fracture Outcomes Associated with Bisphosphonate Use
-
批准号:8818973
-
项目类别:
-
资助金额:$49.16万
-
财政年份:2015
-
负责人:Joan C Lo
-
依托单位:
Femur Fracture Outcomes Associated with Bisphosphonate Use
-
批准号:9191332
-
项目类别:
-
资助金额:$50.63万
-
财政年份:2015
-
负责人:Joan C Lo
-
依托单位:
ESRD Endocrinopathy and Daily Dialysis
-
批准号:8119109
-
项目类别:
-
资助金额:$22.64万
-
财政年份:2010
-
负责人:Joan C Lo
-
依托单位:
ESRD Endocrinopathy and Daily Dialysis
-
批准号:8332114
-
项目类别:
-
资助金额:$22.66万
-
财政年份:2010
-
负责人:Joan C Lo
-
依托单位:
Pregnancy Outcomes in Polycystic Ovary Syndrome
-
批准号:7210187
-
项目类别:
-
资助金额:$50.23万
-
财政年份:2007
-
负责人:Joan C Lo
-
依托单位:
Pregnancy Outcomes in Polycystic Ovary Syndrome
-
批准号:7650015
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2007
-
负责人:Joan C Lo
-
依托单位:
Pregnancy Outcomes in Polycystic Ovary Syndrome
-
批准号:7430262
-
项目类别:
-
资助金额:$49.61万
-
财政年份:2007
-
负责人:Joan C Lo
-
依托单位:
BONE MINERAL DENSITY AND BONE METABOLISM IN HIV
-
批准号:7203023
-
项目类别:
-
资助金额:$10.92万
-
财政年份:2004
-
负责人:Joan C Lo
-
依托单位:
Bone mineral density and bone metabolism in HIV
-
批准号:7044932
-
项目类别:
-
资助金额:$19.15万
-
财政年份:2003
-
负责人:Joan C Lo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: